SUPN R&D to Revenue
Supernus Pharmaceuticals Inc · R&D to Revenue
SUPN R&D to Revenue
Latest reported14.78%period ending
SUPN FY R&D/Revenue (455.16% → 14.78%)
Latest values, visible window
High-resolution chart · PNG
SUPN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 14.7764% | |
| 16.439% | |
| 15.0765% | |
| 11.1732% | |
| 15.6038% | |
| 14.5967% | |
| 17.5934% | |
| 21.817% | |
| 16.4033% | |
| 19.9025% | |
| 20.1728% | |
| 16.0482% | |
| 143.4812% | |
| 1,588.9865% | |
| 3,814.0722% | |
| 33,159.434% | |
| 77.1523% | |
| 342.7045% | |
| 455.1591% |